AAAAAA

   
Results: 1-16 |
Results: 16

Authors: CARLET J CORDONNIER C DECAZES JM KORINEK AM PETITPRETZ P ROTMAN N ACAR J BENHAMOU D BEYTOUT J BUISSON Y CHOUTET P DUROCHER A JARLIER V MLIKACABANNE N MONNET D REGNIER B RICHET H SCHLEMMER B SINEGRE M SOUSSY CJ TREMOLIERES F VERNETGARNIER V WOLFF M ABADIE E ARDUIN M BECKGIRAUDON B BEDOCK B BERARDI L BERNARD C BLECH MF BORNET JL BOULARD G BRUNBUISSON C CARBON C CHAPERON J CHARBONNEAU P COURVALIN P DAVID P DEMICCO P DESBONNETS GP DELCOURT S DEROUBAIX P DESFARGES R DHAVELOOZE A DIEN G DRUCKER J DUBERNET J DUBOIS D DUCREUX AM DUROUX P DUTILLEUL P FABRE X FABRY J FAGNIEZ PL FLANDROIS JP FRANCIOLI P GACHIE JP GALLIACI JL GOTTOT S GOUET D GOUIN F HOUSSIN D JONQUET O JOURDAN J LABADIE JC LACORE V LAGEL R LAXENAIRE MC LEJEUNE B LEMAIRE C LEROY J MAZEMAN P MECHALY P MERY D MICOUD M MOULRONT S NORDIN JY NOUVEAU J PENALBA C PORTIER H POUPENEY M RAZES C RIGNIER P ROUBERTIE E THABAUT A VEYSSIER P VIBET MN WEBER M WELCKER Y WITVOET J
Citation: J. Carlet et al., OPTIMAL USE OF ANTIMICROBIALS IN HOSPITAL IZED-PATIENTS - RECOMMENDATIONS FOR LIMITING THE EMERGENCE OF BACTERIAL-RESISTANCE, La Semaine des hopitaux de Paris, 73(5-6), 1997, pp. 153-158

Authors: CARSENTIETESSE H ROGER PM NISSEDURGEAT S THABAUT A DELLAMONICA P
Citation: H. Carsentietesse et al., IN-VITRO DEVELOPMENT OF STREPTOCOCCUS-PNE UMONIAE RESISTANCE TO BETA-LACTAM ANTIBIOTICS, Medecine et maladies infectieuses, 26(12), 1996, pp. 1194-1195

Authors: SOUSSY CJ CLUZEL M DERLOT E EXMELIN L KITZIS M DABERNAT H LENOC P MULLERSERIEYS C REVERDY ME SCHEFTEL JM THABAUT A
Citation: Cj. Soussy et al., IN-VITRO ANTIBACTERIAL ACTIVITY OF THE NE W FLUOROQUINOLONE SPARFLOXACIN ON NOSOCOMIAL BACTERIA, AND CONCORDANCE CURVE, Pathologie et biologie, 44(4), 1996, pp. 241-248

Authors: CARSENTIETESSE H ROGER PM DUNAIS B MANCINI G THABAUT A DELLAMONICA P
Citation: H. Carsentietesse et al., IN-VITRO SELECTION OF STREPTOCOCCUS-PNEUMONIAE STRAINS WITH DECREASEDSUSCEPTIBILITY TO BETA-LACTAMS AND MACROLIDES, Current therapeutic research, 57(10), 1996, pp. 735-746

Authors: CARSENTIETESSE H DURANT J DESALVADOR F BENSOUSSAN M BENSOUSSAN F PRADIER C THABAUT A DELLAMONICA P
Citation: H. Carsentietesse et al., IN-VITRO DEVELOPMENT OF RESISTANCE OF STREPTOCOCCUS-PNEUMONIAE TO BETA-LACTAM ANTIBIOTICS, Microbial drug resistance, 1(1), 1995, pp. 85-94

Authors: THABAUT A AVRIL JL BEBEAR C BERGOGNEBEREZIN E BOUCOT I CHICHE D CLUZEL R JARLIER V GROSSET J LEMELAND JF MEYRAN M MONTEIL H MOREL C NICOLAS MH PHILIPPON A REVERDY ME SIROT J
Citation: A. Thabaut et al., EVOLUTION OF SUSCEPTIBILITY TO CEFTAZIDIM E AND 3 OTHER BETA-LACTAM AGENTS AGAINST GRAM-NEGATIVE BACILLI IN-HOSPITAL BETWEEN 1989 AND 1993, Medecine et maladies infectieuses, 25, 1995, pp. 6-19

Authors: CARSENTIETESSE H DURANT J SALVADOR F BENSOUSSAN M BENSOUSSAN F PRADIER C THABAUT A DELLAMONICA P
Citation: H. Carsentietesse et al., IN-VITRO DEVELOPMENT OF RESISTANCE TO BETA-LACTAM ANTIBIOTICS IN STREPTOCOCCUS-PNEUMONIAE, Journal of antimicrobial chemotherapy, 36(2), 1995, pp. 417-423

Authors: SOUSSY CJ CLUZEL R COURVALIN P ACAR JF BERGOGNEBEREZIN E CHABBERT Y COURTIEU A DABERNAT H DRUGEON H DUVAL J FLANDROIS JP FLEURETTE J GOLDSTEIN F MEYRAN M MOREL C PHILIPPON A SIROT J THABAUT A VERON M
Citation: Cj. Soussy et al., DEFINITION AND DETERMINATION OF IN-VITRO ANTIBIOTIC SUSCEPTIBILITY BREAKPOINTS FOR BACTERIA IN FRANCE, European journal of clinical microbiology & infectious diseases, 13(3), 1994, pp. 238-246

Authors: CARSENTIETESSE H DURANT J DESALVADOR F BENSOUSSAN M BENSOUSSAN F PRADIER C BERNARD E MONDAIN V THABAUT A DELLAMONICA P
Citation: H. Carsentietesse et al., POSSIBLE PREVENTION OF IN-VITRO SELECTION OF RESISTANT STREPTOCOCCUS-PNEUMONIAE BY BETA-LACTAMASE INHIBITORS, European journal of clinical microbiology & infectious diseases, 13(12), 1994, pp. 1058-1062

Authors: THABAUT A
Citation: A. Thabaut, COMBINED BETA-LACTAMINE AND AMINOSIDE, La Presse medicale, 23(10), 1994, pp. 460-461

Authors: THABAUT A MEYRAN M SOFER L MORAND A LABIA R
Citation: A. Thabaut et al., INTERACTIONS OF CEFTIBUTEN WITH EXTENDED-SPECTRUM BETA-LACTAMASES - ABACTERIOLOGICAL AND ENZYMATIC ANALYSIS, Drugs under experimental and clinical research, 20(2), 1994, pp. 49-54

Authors: THABAUT A MEYRAN M FABRE R DELLAMONICA P MOREAU N
Citation: A. Thabaut et al., IN-VITRO ACTIVITY OF PEFLOXACIN AGAINST C LINICAL ISOLATES - PRESENT STATUS - CROSS-RESISTANCE WITH OFLOXACIN AND CIPROFLOXACIN, Pathologie et biologie, 42(5), 1994, pp. 369-374

Authors: FANTIN B FARINOTTI R THABAUT A CARBON C
Citation: B. Fantin et al., CONDITIONS FOR THE EMERGENCE OF RESISTANCE TO CEFPIROME AND CEFTAZIDIME IN EXPERIMENTAL ENDOCARDITIS DUE TO PSEUDOMONAS-AERUGINOSA, Journal of antimicrobial chemotherapy, 33(3), 1994, pp. 563-569

Authors: RICHARD P MEYRAN M CARPENTIER E THABAUT A DRUGEON HB
Citation: P. Richard et al., COMPARISON OF PHENOTYPIC METHODS AND DNA HYBRIDIZATION FOR DETECTION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS, Journal of clinical microbiology, 32(3), 1994, pp. 613-617

Authors: ACAR J BERGOGNEBEREZIN E BROGARD JM CHABBERT Y CLUZEL R COURVALIN P DABERNAT H DRUGEON H DUBREUIL L DUVAL J FLANDROIS JP FLEURETTE J GOLDSTEIN F MEYRAN M MOREL C PHILIPPON A SIROT J SOUSSY CJ THABAUT A VERON M
Citation: J. Acar et al., 1993 STATEMENT OF THE ANTIBIOGRAM COMMITT EE OF THE FRENCH SOCIETY FOR MICROBIOLOGY, Pathologie et biologie, 41(8), 1993, pp. 741-748

Authors: DUVAL J SOUSSY CJ ACAR JF BERGOGNEBEREZIN E CLUZEL R THABAUT A COURVALIN P GRES JJ ROLLIN C
Citation: J. Duval et al., IN-VITRO ANTIBACTERIAL ACTIVITY OF CEFEPIME - A MULTICENTER STUDY, Journal of antimicrobial chemotherapy, 32, 1993, pp. 55-61
Risultati: 1-16 |